Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs

As the recent development of high-throughput technologies in cancer pharmacogenomics, there is an urgent need to develop new computational approaches for comprehensive identification of new pharmacogenomic biomarkers, such as microRNAs (miRNAs). In this study, a network-based framework, namely the S...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Lei, Kecheng, Wu, Zengrui, Li, Weihua, Liu, Guixia, Liu, Jianwen, Cheng, Feixiong, Tang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216744/
https://www.ncbi.nlm.nih.gov/pubmed/27329603
http://dx.doi.org/10.18632/oncotarget.10052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216744/
https://www.ncbi.nlm.nih.gov/pubmed/27329603
http://dx.doi.org/10.18632/oncotarget.10052

Ejemplares similares